$KPTI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Karyopharm Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Karyopharm Therapeutics Inc.. Get notifications about new insider transactions in Karyopharm Therapeutics Inc. for free.
Page: < prev 1 2 3 4 5 6 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.39 | 5,000 | 51,950 | 16,653 | 11.7 K to 16.7 K (+42.91 %) |
| Dec 10 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 6.54 | 5,000 | 32,700 | 11,653 | 6.7 K to 11.7 K (+75.15 %) |
| Nov 12 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 450,303 | |
| Nov 12 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 406,061 | |
| Nov 12 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.63 | 10,000 | 146,254 | 731,134 | 741.1 K to 731.1 K (-1.35 %) |
| Nov 12 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 741,134 | 731.1 K to 741.1 K (+1.37 %) |
| Nov 12 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.76 | 10,000 | 147,610 | 529,767 | 539.8 K to 529.8 K (-1.85 %) |
| Nov 12 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 539,767 | 529.8 K to 539.8 K (+1.89 %) |
| Nov 05 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 460,303 | |
| Nov 05 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 416,061 | |
| Nov 05 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.00 | 10,000 | 120,000 | 731,134 | 741.1 K to 731.1 K (-1.35 %) |
| Nov 05 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 741,134 | 731.1 K to 741.1 K (+1.37 %) |
| Nov 05 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.00 | 10,000 | 120,000 | 529,767 | 539.8 K to 529.8 K (-1.85 %) |
| Nov 05 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 539,767 | 529.8 K to 539.8 K (+1.89 %) |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 470,303 | |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 426,061 | |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.00 | 10,000 | 120,000 | 731,134 | 741.1 K to 731.1 K (-1.35 %) |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 741,134 | 731.1 K to 741.1 K (+1.37 %) |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.00 | 10,000 | 120,000 | 529,767 | 539.8 K to 529.8 K (-1.85 %) |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 539,767 | 529.8 K to 539.8 K (+1.89 %) |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 426,061 | |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 426,061 | |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 470,303 | |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 470,303 | |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 12.00 | 10,000 | 120,000 | 529,767 | 539.8 K to 529.8 K (-1.85 %) |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 12.00 | 10,000 | 120,000 | 529,767 | 539.8 K to 529.8 K (-1.85 %) |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 539,767 | 529.8 K to 539.8 K (+1.89 %) |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 539,767 | 529.8 K to 539.8 K (+1.89 %) |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 12.00 | 10,000 | 120,000 | 731,134 | 741.1 K to 731.1 K (-1.35 %) |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 12.00 | 10,000 | 120,000 | 731,134 | 741.1 K to 731.1 K (-1.35 %) |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 741,134 | 731.1 K to 741.1 K (+1.37 %) |
| Sep 17 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 741,134 | 731.1 K to 741.1 K (+1.37 %) |
| Jul 15 2019 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Option Exercise | A | 0.00 | 9,650 | 0 | 9,650 | |
| Jul 15 2019 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Option Exercise | A | 7.61 | 25,700 | 195,577 | 25,700 | |
| Jun 07 2019 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 5.43 | 25,000 | 135,750 | 25,000 | |
| Jun 07 2019 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | A | 5.43 | 25,000 | 135,750 | 25,000 | |
| Jun 07 2019 | KPTI | Karyopharm Therape ... | Greene Barry E | Director | Option Exercise | A | 5.43 | 25,000 | 135,750 | 25,000 | |
| Jun 07 2019 | KPTI | Karyopharm Therape ... | Garland J. Scott | Director | Option Exercise | A | 5.43 | 25,000 | 135,750 | 25,000 | |
| Jun 07 2019 | KPTI | Karyopharm Therape ... | Dolsten Mikael | Director | Option Exercise | A | 5.43 | 25,000 | 135,750 | 25,000 | |
| Jun 07 2019 | KPTI | Karyopharm Therape ... | BOHLIN GAREN G | Director | Option Exercise | A | 5.43 | 25,000 | 135,750 | 25,000 | |
| Mar 04 2019 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 4.14 | 149,624 | 619,114 | 6,000,000 | 6.1 M to 6 M (-2.43 %) |
| Feb 27 2019 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 4.51 | 558,243 | 2,515,834 | 6,149,624 | 6.7 M to 6.1 M (-8.32 %) |
| Feb 27 2019 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 5.00 | 123,400 | 617,210 | 6,707,867 | 6.8 M to 6.7 M (-1.81 %) |
| Feb 27 2019 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 4.99 | 800,000 | 3,994,880 | 6,831,267 | 7.6 M to 6.8 M (-10.48 %) |
| Feb 25 2019 | KPTI | Karyopharm Therape ... | Mason Michael | SVP, CFO & Treasure ... | Option Exercise | A | 5.06 | 150,000 | 759,000 | 150,000 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Peters Cameron | VP of Finance | Option Exercise | A | 0.00 | 8,500 | 0 | 8,500 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Peters Cameron | VP of Finance | Option Exercise | A | 9.21 | 17,000 | 156,570 | 17,000 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Varadan Anand | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 38,700 | 0 | 38,700 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Varadan Anand | EVP, Chief Commerci ... | Option Exercise | A | 9.21 | 102,800 | 946,788 | 102,800 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Frenkel Ran | Chief Dev Operation ... | Option Exercise | A | 0.00 | 38,700 | 0 | 38,700 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Frenkel Ran | Chief Dev Operation ... | Option Exercise | A | 9.21 | 102,800 | 946,788 | 102,800 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 0.00 | 87,200 | 0 | 87,200 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 0.00 | 87,200 | 0 | 87,200 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 9.21 | 231,200 | 2,129,352 | 231,200 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 9.21 | 231,200 | 2,129,352 | 231,200 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 0.00 | 87,200 | 0 | 87,200 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 0.00 | 87,200 | 0 | 87,200 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 9.21 | 231,200 | 2,129,352 | 231,200 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 9.21 | 231,200 | 2,129,352 | 231,200 | |
| Jan 09 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 12,500 | 413 | 15,357 | |
| Jan 09 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 10.23 | 12,500 | 127,824 | 731,134 | 743.6 K to 731.1 K (-1.68 %) |
| Jan 09 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 12,500 | 413 | 743,634 | 731.1 K to 743.6 K (+1.71 %) |
| Jan 09 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 12,500 | 413 | 15,357 | |
| Jan 09 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 10.23 | 12,500 | 127,824 | 731,134 | 743.6 K to 731.1 K (-1.68 %) |
| Jan 09 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 12,500 | 413 | 743,634 | 731.1 K to 743.6 K (+1.71 %) |
| Dec 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 12,500 | 413 | 27,857 | |
| Dec 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 10.11 | 12,500 | 126,423 | 713,510 | 726 K to 713.5 K (-1.72 %) |
| Dec 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 12,500 | 413 | 726,010 | 713.5 K to 726 K (+1.75 %) |
| Dec 10 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 12,500 | 413 | 27,857 | |
| Dec 10 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 10.11 | 12,500 | 126,423 | 713,510 | 726 K to 713.5 K (-1.72 %) |
| Dec 10 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 12,500 | 413 | 726,010 | 713.5 K to 726 K (+1.75 %) |
| Nov 27 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 9,600 | 45,619 | 436,061 | |
| Nov 27 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 11.00 | 9,600 | 105,600 | 512,143 | 521.7 K to 512.1 K (-1.84 %) |
| Nov 27 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 9,600 | 45,619 | 521,743 | 512.1 K to 521.7 K (+1.87 %) |
| Nov 27 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 9,600 | 45,619 | 436,061 | |
| Nov 27 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 11.00 | 9,600 | 105,600 | 512,143 | 521.7 K to 512.1 K (-1.84 %) |
| Nov 27 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 9,600 | 45,619 | 521,743 | 512.1 K to 521.7 K (+1.87 %) |
| Nov 21 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 400 | 1,901 | 445,661 | |
| Nov 21 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 11.14 | 400 | 4,455 | 512,143 | 512.5 K to 512.1 K (-0.08 %) |
| Nov 21 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 400 | 1,901 | 512,543 | 512.1 K to 512.5 K (+0.08 %) |
| Nov 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 400 | 1,901 | 445,661 | |
| Nov 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 11.14 | 400 | 4,455 | 512,143 | 512.5 K to 512.1 K (-0.08 %) |
| Nov 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 400 | 1,901 | 512,543 | 512.1 K to 512.5 K (+0.08 %) |
| Nov 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 12,500 | 413 | 40,357 | |
| Nov 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 11.65 | 12,500 | 145,593 | 713,510 | 726 K to 713.5 K (-1.72 %) |
| Nov 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 12,500 | 413 | 726,010 | 713.5 K to 726 K (+1.75 %) |
| Nov 09 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 12,500 | 413 | 40,357 | |
| Nov 09 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 11.65 | 12,500 | 145,593 | 713,510 | 726 K to 713.5 K (-1.72 %) |
| Nov 09 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 12,500 | 413 | 726,010 | 713.5 K to 726 K (+1.75 %) |
| Oct 22 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 446,061 | |
| Oct 22 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 12.63 | 10,000 | 126,304 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Oct 22 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Oct 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 446,061 | |
| Oct 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.63 | 10,000 | 126,304 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Oct 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Oct 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 10,736 | 354 | 52,857 | |
| Oct 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 1,764 | 58 | 0 | |
| Oct 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 16.13 | 6,000 | 96,767 | 713,510 | 719.5 K to 713.5 K (-0.83 %) |
| Oct 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 15.39 | 6,500 | 100,066 | 719,510 | 726 K to 719.5 K (-0.90 %) |
| Oct 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 10,736 | 354 | 726,010 | 715.3 K to 726 K (+1.50 %) |
| Oct 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 1,764 | 58 | 715,274 | 713.5 K to 715.3 K (+0.25 %) |
| Oct 09 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 10,736 | 354 | 52,857 | |
| Oct 09 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 1,764 | 58 | 0 | |
| Oct 09 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 16.13 | 6,000 | 96,767 | 713,510 | 719.5 K to 713.5 K (-0.83 %) |
| Oct 09 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 15.39 | 6,500 | 100,066 | 719,510 | 726 K to 719.5 K (-0.90 %) |
| Oct 09 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 10,736 | 354 | 726,010 | 715.3 K to 726 K (+1.50 %) |
| Oct 09 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 1,764 | 58 | 715,274 | 713.5 K to 715.3 K (+0.25 %) |
| Sep 18 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 456,061 | |
| Sep 18 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 18.26 | 10,000 | 182,615 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Sep 18 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Sep 18 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 456,061 | |
| Sep 18 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.26 | 10,000 | 182,615 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Sep 18 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Sep 11 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.39 | 5,000 | 51,950 | 113,000 | |
| Sep 11 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 6.54 | 5,000 | 32,700 | 18,000 | |
| Sep 11 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 18.90 | 10,000 | 189,046 | 2,881 | 12.9 K to 2.9 K (-77.63 %) |
| Sep 11 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.39 | 5,000 | 51,950 | 12,881 | 7.9 K to 12.9 K (+63.44 %) |
| Sep 11 2018 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 6.54 | 5,000 | 32,700 | 7,881 | 2.9 K to 7.9 K (+173.55 %) |
| Sep 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 12,500 | 413 | 1,764 | |
| Sep 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 19.31 | 12,500 | 241,384 | 713,510 | 726 K to 713.5 K (-1.72 %) |
| Sep 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 12,500 | 413 | 726,010 | 713.5 K to 726 K (+1.75 %) |
| Sep 10 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 12,500 | 413 | 1,764 | |
| Sep 10 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 19.31 | 12,500 | 241,384 | 713,510 | 726 K to 713.5 K (-1.72 %) |
| Sep 10 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 12,500 | 413 | 726,010 | 713.5 K to 726 K (+1.75 %) |
| Sep 07 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 20.52 | 4,800 | 98,474 | 7,631,267 | 7.6 M to 7.6 M (-0.06 %) |
| Sep 07 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 21.06 | 160,000 | 3,370,256 | 7,636,067 | 7.8 M to 7.6 M (-2.05 %) |
| Sep 04 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 20.60 | 40,000 | 824,072 | 7,796,067 | 7.8 M to 7.8 M (-0.51 %) |
| Sep 04 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 21.05 | 11,468 | 241,396 | 7,836,067 | 7.8 M to 7.8 M (-0.15 %) |
| Sep 04 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 21.00 | 200,000 | 4,199,900 | 7,847,535 | 8 M to 7.8 M (-2.49 %) |
| Sep 04 2018 | KPTI | Karyopharm Therape ... | Thiel Carsten | Director | Option Exercise | A | 21.05 | 34,000 | 715,700 | 34,000 | |
| Sep 04 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 5.64 | 264 | 1,490 | 10,342 | |
| Sep 04 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 1.49 | 2,236 | 3,320 | 0 | |
| Sep 04 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 21.00 | 2,500 | 52,500 | 0 | 2.5 K to 0 (-100.00 %) |
| Sep 04 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 5.64 | 264 | 1,490 | 264 | 0 to 264 |
| Sep 04 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 1.49 | 2,236 | 3,320 | 2,236 | 0 to 2.2 K |
| Aug 30 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 1.49 | 2,500 | 3,713 | 2,236 | |
| Aug 30 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 20.00 | 2,500 | 50,000 | 0 | 2.5 K to 0 (-100.00 %) |
| Aug 30 2018 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 1.49 | 2,500 | 3,713 | 2,500 | 0 to 2.5 K |
| Aug 29 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 19.59 | 200,000 | 3,918,280 | 8,047,535 | 8.2 M to 8 M (-2.42 %) |
| Aug 29 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 18.52 | 14,026 | 259,776 | 8,247,535 | 8.3 M to 8.2 M (-0.17 %) |
| Aug 29 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 19.59 | 200,000 | 3,918,280 | 8,047,535 | 8.2 M to 8 M (-2.42 %) |
| Aug 29 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 18.52 | 14,026 | 259,776 | 8,247,535 | 8.3 M to 8.2 M (-0.17 %) |
| Aug 21 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 466,061 | |
| Aug 21 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 17.46 | 10,000 | 174,568 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Aug 21 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Aug 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 466,061 | |
| Aug 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 17.46 | 10,000 | 174,568 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Aug 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Aug 14 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 18.50 | 702 | 12,987 | 8,261,561 | 8.3 M to 8.3 M (-0.01 %) |
| Aug 09 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 18.51 | 67,474 | 1,248,782 | 8,262,263 | 8.3 M to 8.3 M (-0.81 %) |